Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

The document concludes that proper diagnosis and a combination of medical, hair-care, and surgical treatments are important for managing alopecia in black women.

Women with PCOS often feel stigmatized and have mood issues, which can lower their sexual satisfaction, but proper treatment and support can help.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The conclusion is that self-concept, shame, and emotion regulation are key factors in hoarding disorder, body dysmorphic disorder, and trichotillomania, and should be targeted in treatment and research.

The HPV vaccine may be linked to temporary hair loss in children, but the benefits outweigh the risks.

Acne and other skin conditions can indicate internal diseases like Polycystic Ovary Syndrome (PCOS), and early treatment can prevent long-term issues.

A teenager lost hair due to fluoxetine and sertraline, but it grew back after stopping these drugs and switching to a different one.

30% supramolecular salicylic acid is safe and effective for treating mild to moderate facial acne.

Effective treatment for skin issues in women with PCOS includes oral contraceptives, antiandrogens, and other medications and procedures.

Use corticosteroid cream and triamcinolone injections for treating alopecia areata, and consider wigs and tranquilizers for support.

Hair health depends on various factors and hair loss can significantly affect a person's well-being; understanding hair biology is key for creating effective hair care treatments.

South Asian women with PCOS experience more psychological distress and have a poorer quality of life, especially in social relationships, with hirsutism affecting them more than obesity.

Finasteride can cause serious emotional side effects; doctors should check patients' mental health history before prescribing.

Emotional Freedom Techniques (EFT) treatment improved seed germination and growth, suggesting mood affects seed viability.

Women with PCOS have more emotional and body image issues than healthy women.

Androgenetic alopecia in men aged 46 is not significantly linked to depression, anxiety, quality of life, self-esteem, or sexual symptoms.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

Treating hair loss requires a comprehensive approach that addresses both physical and emotional aspects, with a focus on diagnosis, patient education, and good communication.

Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Women with PCOS are more likely to suffer from depression, anxiety, and stress.

Androgenetic alopecia causes significant psychological distress, especially in women, and requires both medical and psychological support.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

The review suggests that understanding and treating the psychological aspect of skin disorders is important and calls for more collaboration in this field.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.